49 studies found for:    metabolic syndrome | Open Studies | Interventional Studies | Adult | Phase 1, 2, 3 | Industry
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
Condition: Abdominal Obesity Metabolic Syndrome
Interventions: Drug: ALS-L1023;   Drug: placebo
2 Recruiting Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diastolic Dysfunction;   Insulin Resistance
Interventions: Behavioral: Lifestyle Counseling;   Drug: Metformin
3 Recruiting The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome
Conditions: Metabolic Syndrome;   Obesity
Interventions: Dietary Supplement: Coleus forskohlii extract;   Other: Placebo
4 Unknown  Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Conditions: Metabolic Syndrome;   Nonalcoholic Fatty Liver Disease
Intervention: Drug: Sodium Octanoate
5 Unknown  Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)
Condition: Metabolic Disease
Intervention: Dietary Supplement: LaFlavon
6 Recruiting Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar Levels
Conditions: Diabetes Mellitus;   Pre-Diabetes;   Hyperglycemia;   Metabolic Syndrome
Interventions: Dietary Supplement: Study dietary supplement (Precrea 500 mg capsules);   Dietary Supplement: Placebo
7 Recruiting Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Conditions: Gestational Diabetes Mellitus;   Type 2 Diabetes Mellitus;   Metabolic Syndrome;   Impaired Glucose Tolerance;   Disorder of Glucose Regulation
Interventions: Drug: Metformin XR plus placebo;   Drug: Metformin XR  plus liraglutide
8 Recruiting A Parallel Study Evaluating the Effect of A-F Betafood® on Gallbladder and Liver Function.
Condition: Gallbladder
Intervention: Dietary Supplement: A-F Betafood
9 Recruiting Effects of Obex in Overweight and Obese Patients
Conditions: Overweight;   Obesity
Intervention: Dietary Supplement: Obex
10 Unknown  Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men
Conditions: Aging;   Obesity;   Insulin Resistance;   Hypogonadism
Intervention: Drug: Topical testosterone (Androgel) 10 g/day
11 Recruiting Phase 2 Study of EPI-743 in Children With Pearson Syndrome
Condition: Pearson Syndrome
Intervention: Drug: EPI-743
12 Not yet recruiting Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
Conditions: Primary Immune Deficiency Disorders;   Hemophagocytic Lymphohistiocytosis;   Inherited Bone Marrow Failure Syndrome;   Hemoglobinopathies;   Metabolic Disorders
Intervention: Biological: BPX-501 and AP1903
13 Recruiting Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
Condition: Glucose Transporter Type 1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
14 Recruiting An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Intervention: Drug: Triheptanoin
15 Not yet recruiting A Phase 3 Study of UX003 rhGUS Enzyme Replacement Therapy in Patients With MPS 7
Conditions: MPS 7;   Sly Syndrome;   Mucopolysaccharidosis;   MPS VII
Intervention: Drug: UX003
16 Recruiting Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Condition: Nonmalignant Neoplasm
Interventions: Drug: treosulfan;   Drug: fludarabine phosphate;   Biological: anti-thymocyte globulin;   Radiation: total-body irradiation;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Drug: tacrolimus;   Drug: methotrexate;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Other: laboratory biomarker analysis
17 Not yet recruiting PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
Conditions: Polycystic Ovary Syndrome (PCOS);   Insulin Resistance
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo metformin;   Drug: Placebo DLBS3233
18 Recruiting Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Interventions: Drug: UX007 (triheptanoin);   Drug: Placebo Oil
19 Recruiting Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Condition: Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Drug: Deferasirox placebo
20 Recruiting Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome (PCOS)
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo caplet of Metformin XR;   Drug: Placebo capsule of DLBS3233

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years